-
公开(公告)号:US06610695B1
公开(公告)日:2003-08-26
申请号:US09445652
申请日:2000-03-22
申请人: Jerry L. Adams , Dennis Lee , Scott A. Long
发明人: Jerry L. Adams , Dennis Lee , Scott A. Long
IPC分类号: A61K31506
CPC分类号: C07D403/04
摘要: Novel 2,4,5-triaryl substituted imidazole compounds and compositions for use in therapy of CSBP/RK/p38 mediated diseases.
摘要翻译: 新型2,4,5-三芳基取代的咪唑化合物和用于治疗CSBP / RK / p38介导的疾病的组合物。
-
公开(公告)号:US06514992B1
公开(公告)日:2003-02-04
申请号:US09719724
申请日:2000-12-14
申请人: Dennis Lee , Scott A. Long
发明人: Dennis Lee , Scott A. Long
IPC分类号: A61K31445
CPC分类号: C07D207/08
摘要: The present invention is to novel compounds of Formula (I), their pharmaceutical compositions, and to the novel inhibition of Caspases for use in the treatment of apoptosis, and disease states caused by excessive or inappropriate cell death.
摘要翻译: 本发明是新型式(I)化合物,其药物组合物,以及用于治疗凋亡的胱天蛋白酶的新型抑制,以及由过度或不适当的细胞死亡引起的疾病状态。
-
公开(公告)号:US20100113465A1
公开(公告)日:2010-05-06
申请号:US12573897
申请日:2009-10-06
申请人: Scott A. Long , Marvin J. Meyers , Matthew J. Pelc , Barbara A. Schweitzer , Atli Thorarensen , Jane L. Wang
发明人: Scott A. Long , Marvin J. Meyers , Matthew J. Pelc , Barbara A. Schweitzer , Atli Thorarensen , Jane L. Wang
IPC分类号: A61K31/501 , C07D221/20 , A61K31/438 , A61P29/00 , C07D401/14
CPC分类号: C07D403/14 , C07D403/12
摘要: Provided herein are 7-azaspiro[3.5]nonane-7-carboxamide compounds and the pharmaceutically acceptable salts of such compounds useful in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, conditions including including acute pain, chronic pain, neuropathic pain, nociceptive pain, inflammatory pain, cancer and cancer pain, fibromyalgia, rheumatoid arthritis, inflammatory bowel disease, lupus, diabetes, allergic asthma, vascular inflammation, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.
摘要翻译: 本文提供的是7-氮杂螺[3.5]壬烷-7-甲酰胺化合物和可用于治疗与脂肪酰胺水解酶(FAAH)活性相关的疾病或病症的化合物的药学上可接受的盐,包括急性疼痛,慢性疼痛,神经性 疼痛,伤害性疼痛,炎性疼痛,癌症和癌症疼痛,纤维肌痛,类风湿性关节炎,炎性肠病,狼疮,糖尿病,过敏性哮喘,血管炎症,尿失禁,膀胱过度活动,呕吐,认知障碍,焦虑症,抑郁症,睡眠障碍, 饮食失调,运动障碍,青光眼,牛皮癣,多发性硬化,脑血管障碍,脑损伤,胃肠道疾病,高血压或心血管疾病。
-
公开(公告)号:US20120035131A1
公开(公告)日:2012-02-09
申请号:US13277270
申请日:2011-10-20
申请人: Marvin J. Meyers , Graciela B. Arhancet , Xiangyang Chen , Susan Hockerman , Scott A. Long , Matthew W. Mahoney , David B. Reitz , Joseph G. Rico
发明人: Marvin J. Meyers , Graciela B. Arhancet , Xiangyang Chen , Susan Hockerman , Scott A. Long , Matthew W. Mahoney , David B. Reitz , Joseph G. Rico
IPC分类号: A61K31/695 , C07D401/04 , C07D417/04 , C07D261/08 , C07D405/04 , C07D401/12 , C07F7/08 , A61K31/416 , A61K31/454 , A61K31/427 , A61K31/422 , A61K31/4439 , A61P9/12 , A61P9/10 , A61P25/00 , A61P25/02 , A61P9/00 , C07D231/54
CPC分类号: C07D231/54 , C07D401/04 , C07D405/04 , C07D493/04
摘要: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R1, R2, R3A, R3B, R4, R5, R6, R7, R8, and X are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, and intermediates are also disclosed.
摘要翻译: 公开了化合物的化合物和药学上可接受的盐,其中所述化合物具有式I的结构:其中R1,R2,R3A,R3B,R4,R5,R6,R7,R8和X如在 本发明。 还公开了相应的药物组合物,治疗方法和中间体。
-
公开(公告)号:US20100280016A1
公开(公告)日:2010-11-04
申请号:US12834117
申请日:2010-07-12
申请人: Marvin J. Meyers , Graciela B. Arhancet , XiangYang Chen , Susan Hockerman , Scott A. Long , Matthew W. Mahoney , David B. Reitz , Joseph G. Rico
发明人: Marvin J. Meyers , Graciela B. Arhancet , XiangYang Chen , Susan Hockerman , Scott A. Long , Matthew W. Mahoney , David B. Reitz , Joseph G. Rico
IPC分类号: A61K31/416 , C07D231/54 , C07D401/04 , C07D491/052 , A61K31/4439 , A61K31/454 , A61K31/4162 , A61K31/5415 , A61K31/517 , A61P9/00 , A61P13/12 , A61P1/16 , A61P29/00 , A61P25/00
CPC分类号: C07D231/54 , C07D401/04 , C07D405/04 , C07D493/04
摘要: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R1, R2, R3A, R3B, R4, R5, R6, R7, R8, and X are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, and intermediates are also disclosed.
摘要翻译: 公开了化合物的化合物和药学上可接受的盐,其中所述化合物具有式I的结构:其中R1,R2,R3A,R3B,R4,R5,R6,R7,R8和X如在 本发明。 还公开了相应的药物组合物,治疗方法和中间体。
-
6.Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade 失效
标题翻译: 用于选择性抑制凝血级联的取代的多环芳基和杂芳基吡嗪酮公开(公告)号:US06664255B1
公开(公告)日:2003-12-16
申请号:US09574752
申请日:2000-05-18
申请人: Michael South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Horng-Chih Huang , Wei Huang , Scott A. Long , Matthew Mahoney , William L. Neumann , David Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Rick Fenton , Gary W. Franklin , Carrie Kusturin
发明人: Michael South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Horng-Chih Huang , Wei Huang , Scott A. Long , Matthew Mahoney , William L. Neumann , David Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Rick Fenton , Gary W. Franklin , Carrie Kusturin
IPC分类号: C07D24120
CPC分类号: C07D417/12 , A61K38/00 , C07D241/20 , C07D401/12 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07K5/06139 , C07K5/06191
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
摘要翻译: 本发明涉及可用作凝血级联丝氨酸蛋白酶抑制剂的取代的多环芳基和杂芳基吡嗪酮化合物,以及用于治疗和预防各种血栓形成病症(包括冠状动脉和脑血管疾病)的抗凝血治疗的化合物,组合物和方法。
-
公开(公告)号:US20080167294A1
公开(公告)日:2008-07-10
申请号:US11923248
申请日:2007-10-24
申请人: Marvin J. Meyers , Graciela B. Arhancet , Xiangyang Chen , Susan Hockerman , Scott A. Long , Matthew W. Mahoney , David B. Reitz , Joseph G. Rico
发明人: Marvin J. Meyers , Graciela B. Arhancet , Xiangyang Chen , Susan Hockerman , Scott A. Long , Matthew W. Mahoney , David B. Reitz , Joseph G. Rico
IPC分类号: A61K31/546 , C07D231/54 , A61K31/416 , A61K31/44 , A61P9/00 , A61P9/12
CPC分类号: C07D231/54 , C07D401/04 , C07D405/04 , C07D493/04
摘要: Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R1, R2, R3A, R3B, R4, R5, R6, R7, R8, and X are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, and intermediates are also disclosed.
摘要翻译: 公开了化合物的化合物和药学上可接受的盐,其中所述化合物具有式I的结构:其中R 1,R 2,R 3A, R 3,R 4,R 4,R 5,R 6,R 7, >,R 8,X如本发明的详细描述中所定义。 还公开了相应的药物组合物,治疗方法和中间体。
-
8.Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade 失效
标题翻译: 用于选择性抑制凝血级联的取代的多环芳基和异齿酰基吡嗪酮公开(公告)号:US07119094B1
公开(公告)日:2006-10-10
申请号:US10276174
申请日:2000-11-20
申请人: Michael S. South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Rick Fenton , Gary W. Franklin , Horng-Chih Huang , Wei Huang , Carrie Kusturin , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney
发明人: Michael S. South , John J. Parlow , Darin E. Jones , Brenda Case , Tom Dice , Richard Lindmark , Michael J. Hayes , Melvin L. Rueppel , Rick Fenton , Gary W. Franklin , Horng-Chih Huang , Wei Huang , Carrie Kusturin , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney
IPC分类号: A61K31/4965 , C07D241/02
CPC分类号: C07D417/12
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
摘要翻译: 本发明涉及可用作凝血级联丝氨酸蛋白酶抑制剂的取代的多环芳基和杂芳基吡嗪酮化合物,以及用于治疗和预防各种血栓形成病症(包括冠状动脉和脑血管疾病)的抗凝血治疗的化合物,组合物和方法。
-
9.Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade 失效
标题翻译: 用于选择性抑制凝血级联的取代的多环芳基和杂芳基吡嗪酮公开(公告)号:US06908919B2
公开(公告)日:2005-06-21
申请号:US10195573
申请日:2002-07-15
申请人: Michael S. South , Brenda L. Case , Thomas A. Dice , Ricky L. Fenton , Gary W. Franklin , Michael J. Hayes , Horng-Chih Huang , Wei Huang , Darin E. Jones , Carrie L. Kusturin , Richard J. Lindmark , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney , John J. Parlow , Melvin L. Rueppel
发明人: Michael S. South , Brenda L. Case , Thomas A. Dice , Ricky L. Fenton , Gary W. Franklin , Michael J. Hayes , Horng-Chih Huang , Wei Huang , Darin E. Jones , Carrie L. Kusturin , Richard J. Lindmark , Scott A. Long , William L. Neumann , David B. Reitz , John I. Trujillo , Ching-Cheng Wang , Rhonda Wood , Qingping Zeng , Matthew W. Mahoney , John J. Parlow , Melvin L. Rueppel
IPC分类号: A61K38/00 , C07D241/20 , C07D401/12 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07K5/06 , C07K5/078 , A61K31/495 , A61P7/02
CPC分类号: C07D401/12 , A61K38/00 , C04B35/632 , C07D241/20 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D413/12 , C07D417/12 , C07K5/06139 , C07K5/06191
摘要: The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.
摘要翻译: 本发明涉及可用作凝血级联丝氨酸蛋白酶抑制剂的取代的多环芳基和杂芳基吡嗪酮化合物,以及用于治疗和预防各种血栓形成病症(包括冠状动脉和脑血管疾病)的抗凝血治疗的化合物,组合物和方法。
-
-
-
-
-
-
-
-